** Shares of Artrya AYA.AX fall as much 9% to A$0.455,
their lowest level since Oct 23
** The medical technology co receives firm commitments to
raise A$5 mln ($3.29 mln) via placement
** Issue price of A$0.42 represents 16% discount to co's
last close on Thursday, Nov. 7
** Adds, fund raised to be allocated to product development,
others, as co awaits FDA clearance on its patented Salix
Coronary Anatomy product
** Stock up 95.8% this year, including session's moves
($1 = 1.5221 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))